Some of the biggest health insurers confirmed goals this week to offer plans over state-based exchanges set to launch late this year, but they’re moving cautiously while waiting to learn more about these new markets.
Exchanges are a hot topic at the annual J.P. Morgan health-care conference this week because they could offer significant new business by extending coverage, sometimes backed by subsidies through the health-care overhaul law, to millions of Americans. PricewaterhouseCoopers has estimated the markets could create $55 billion in premiums next year and $205 billion by 2021.
Read the full story: http://on.wsj.com/XpVWq4
Source: The Wall Street Journal
Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 1
November 10th 2023In part 1 of this 2-part podcast, a panel of experts discusses the provider and payer considerations for transitioning patients to biosimilars, approaches to prescribing biosimilars over reference products, and more.
Listen
Disease-Modifying Antirheumatic Drugs Linked to Decreased Risk for Autoimmune Thyroid Disease
November 28th 2023A nationwide cohort study linked biologic disease-modifying antirheumatic drugs with decreased risks for the onset of autoimmune thyroid disease in patients with rheumatoid arthritis.
Read More